Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04514926 · ClinicalTrials.gov registry record
Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 62
- Enrollment target
NCT04514926 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 62 participants.
The verdict
NCT04514926 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This is an observational, clinic-based, single center study of 120 subjects. Participants will be comprised of patients seen in the outpatient faculty practice in ambulatory care at the UCSF Parnassus campus. Study investigators will enroll 20 healthy participants with no history of lung disease, 50 asthmatics who are newly prescribed therapeutic proteins for their asthma, and 50 asthmatics already being treated with therapeutic proteins for their asthma. Participants will be seen at 1 to 3 visits and provide blood samples at each visit.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2023-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04514926
The ClinicalTrials.gov registry entry for NCT04514926 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04514926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04514926 about?
NCT04514926 is a clinical study titled "Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins". This is an observational, clinic-based, single center study of 120 subjects. Participants will be comprised of patients seen in the outpatient faculty practice in ambulatory care at the UCSF Parnassus campus. Study investigators will enroll 20 healthy participants with no history of lung disease, 50...
What is the current status of trial NCT04514926?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2020-11-01. Estimated completion is 2023-05-26.
Who is sponsoring clinical trial NCT04514926?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.